Aaron Brinkworth

Aaron Brinkworth

Net worth: 13 126 $ as of 31/05/2026

Health Services
Health Technology
Consumer Services

Profile

Aaron Brinkworth is Chairman at Resonance Health Ltd. starting in 2025.
Mr. Brinkworth is Director at Lixa Pty Ltd. Mr. Brinkworth is Independent Non-Executive Director at Proteomics International Laboratories Ltd. starting in 2024.
Mr. Brinkworth was Executive Director-Global Patient Solutions at Gilead Sciences, Inc. from 2018 to 2020.
Mr. Brinkworth completed undergraduate studies at the University of Edith Cowan.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
30/06/2025 135,135 ( 0.08% ) 13 126 $ 31/05/2026

Aaron Brinkworth active positions

CompaniesPositionStart
RESONANCE HEALTH LIMITED Chairman 13/11/2025
PROTEOMICS INTERNATIONAL LABORATORIES LTD Director/Board Member 08/11/2024
Director/Board Member -

Former positions of Aaron Brinkworth

CompaniesPositionEnd
GILEAD SCIENCES, INC. Corporate Officer/Principal 01/08/2020
See the detail of Aaron Brinkworth's experience

Training of Aaron Brinkworth

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

74

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Health Technology

Health Services

Consumer Services

Health Services

Commercial Services

  1. Stock Market
  2. Insiders
  3. Aaron Brinkworth